Metabolic & Weight Research · Research Grade

Semaglutide — The GLP-1 Original

Semaglutide is the peptide that put “GLP-1” on the map. A single-target GLP-1 receptor agonist, it’s the most-studied name in the entire metabolic-peptide wave — the molecule behind years of appetite, blood-sugar and body-weight research. If you’ve heard the phrase “GLP-1,” this is where it started. Published batch documentation is shown on the COA page when a matching record is available.

Appetite researchBody-weight researchBlood-sugar researchGLP-1 receptor
Semaglutide — The GLP-1 Original

Why review Semaglutide with Aeternum Life

Clear intended use

The listing identifies this item as a laboratory research material.

Published specifications

Identity, format, storage, and package information are shown on the product page.

Order-specific delivery

Destination availability, dispatch details, and tracking are confirmed for the order.

Available batch records

COA records appear by product and batch when a matching record is published.

What is Semaglutide?

Semaglutide is a synthetic peptide that mimics GLP-1 (glucagon-like peptide-1), one of the body’s own “incretin” hormones released after you eat. By acting on the GLP-1 receptor, it’s the compound that defined a whole category of metabolic research.

Semaglutide’s reputation is built on the GLP-1 pathway: how appetite, fullness, blood-sugar handling and body weight all connect. It’s the single-receptor foundation that tirzepatide (two receptors) and retatrutide (three) build on. Aeternum Life supplies it as ultra-high-purity research material with a batch-specific Certificate of Analysis on every order.

Research directions

Semaglutide is the most-researched peptide in the metabolic space. Here’s where the work focuses.

GLP-1 receptor action

The foundation: Semaglutide activates the GLP-1 receptor — the single pathway that launched the entire incretin field.

Appetite & satiety

GLP-1 is tied to feelings of fullness, and appetite research is central to Semaglutide’s story.

Body-weight research

Body weight is the headline question the whole GLP-1 field is built around.

Blood sugar & metabolism

As an incretin mimic, Semaglutide is studied for blood-sugar handling and insulin signaling.

Gastric emptying

GLP-1 slows how quickly the stomach empties — a recurring theme in the research.

The GLP-1 benchmark

Semaglutide is the reference every newer incretin peptide is measured against.

For research purposes only. These materials are not drugs or dietary supplements and are not intended to diagnose, treat, cure or prevent any disease.

Telegram

Join the Aeternum Life community

Get research summaries, batch-record updates, restock alerts, and customer support. We do not provide dosing, reconstitution, or administration guidance.

Join our Telegram

Semaglutide documentation

  • Published product specification
  • Reported purity and test date when available
  • Batch number shown on matching records
  • Laboratory and verification details only when supplied

The COA page shows the batch documentation currently published. Missing fields are left blank rather than inferred.

Handling & Storage

Guidance for handling Semaglutide as a laboratory research material.

Storage

Store lyophilized Semaglutide cold and protected from light, sealed and dry until use.

Laboratory handling

Handle Semaglutide according to standard laboratory practice for research materials.

Documentation

Published batch documentation is linked when a matching record is available.

Semaglutide is supplied strictly for laboratory and research use. Not for human or veterinary consumption; no administration or dosing guidance is provided.

Specifications

Name
Semaglutide
CAS
910463-68-2
Class
GLP-1 receptor agonist
Appearance
White lyophilized powder
Size
5 mg / 10 mg per vial
Purity
≥ 99% (HPLC, see COA)
Storage
Store at 2–8°C, protect from light

For research use. Not intended to diagnose, treat, cure or prevent any disease.

Frequently asked questions

What is Semaglutide studied for?

It’s studied in metabolic research around the GLP-1 pathway — appetite, satiety, blood sugar and body weight. We share these as research directions, not medical claims.

Semaglutide, tirzepatide or retatrutide — what’s the difference?

It’s about how many receptors each hits: semaglutide one (GLP-1), tirzepatide two (GLP-1 + GIP), retatrutide three (adds glucagon).

Is Semaglutide for human use?

No. Aeternum Life supplies Semaglutide strictly as a research-grade material for laboratory research. It is not sold for human or veterinary consumption.

Is a COA available for Semaglutide?

Published COA records are available by product and batch when a matching record exists. Laboratory and verification details appear only when stated in that record.

About Aeternum Life

Aeternum Life Limited publishes clearly labeled laboratory research materials and accessories, with specifications and available batch documentation.

Learn more about us

Keep up with the Semaglutide research

New reviews, data and study summaries — sent when there is something worth reading, not on a schedule.

No spam. Unsubscribe anytime.

WhatsApp

Questions before you order?

Message us on WhatsApp for pricing, bulk quotes, stock, shipping and order support — a real person, usually within a few hours.

Message us on WhatsApp

Explore the full Aeternum Life range

Semaglutide is part of the Aeternum Life research catalog. Review its intended-use status, specifications, and any currently published batch record before ordering.

Browse all products

Product and service note

The current catalog contains laboratory research materials and research accessories. Research materials are not medicines or dietary supplements and are not intended for human or veterinary consumption. Product pages show the intended-use status and the batch documentation currently available.

Dr. AeternumStatus · COA · checkout
Hi 👋 I can help you check a product's research-use status, specifications, available COA records, price, delivery, or checkout. The site's catalog matcher can compare research materials by selected priorities. Results are research-only and not medical advice; I do not provide individualized dosing or administration guidance.